HH
TFFP

Hilltop Holdings’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Hilltop Holdings’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-944
Closed -$338K – 568
2020
Q4 		$338K Buy
+944
New +$363K 0.05% 351

Other funds holding TFFP

CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Hilltop Holdings's TFFP Position: Q1 2021 in Review

Hilltop Holdings sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q1 2021, closing a stake of 944 shares — an estimated $338K sold.

Hilltop Holdings first reported a position in TFFP in Q4 2020 and held it in 1 quarter. The position peaked at $338K in Q4 2020. 63 funds tracked by Wall St. Rank hold TFFP as of Q1 2021.

  • Hilltop Holdings reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Hilltop Holdings sold 944 TFF Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $338K.
  • Hilltop Holdings first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Hilltop Holdings's TFF Pharmaceuticals, Inc. Common Stock position peaked at $338K in Q4 2020.
  • 63 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on Hilltop Holdings's 13F filing for Q1 2021, filed 17 May 2021.